Overview
CELLINK is a leading 3D bioprinting company that develops and commercializes advanced bioprinting technologies, bioinks, and biomaterials for life science research and regenerative medicine applications. The company provides extrusion-based and light-based bioprinters, including the BIO X, BIO X6, LUMEN X, BIONOVA X, and BIO ONE platforms, alongside a comprehensive portfolio of bioinks designed for tissue engineering, drug discovery, and personalized medicine. CELLINK's technology enables researchers to create three-dimensional tissue models that more accurately replicate in vivo environments, accelerating drug development and reducing reliance on animal testing. The company serves over 1,600 academic, pharmaceutical, and industrial laboratories globally and has been cited in more than 1,000 peer-reviewed publications. CELLINK operates as a division of BICO Group, a Swedish bioconvergence company focused on advancing biology research through integrated technology platforms.